Group 3 – Severely impaired relaxation 1 (3.6%) 2 (11.1%) 7 (38.9%) 8 (44.4%) Values are number of subjects (%). Impaired relaxation (group 1) indicates low age-specific E:A and normal E:E'; elevated ...

There exists a sub group of patients with uremic cardiomyopathy who experience resolution of heart failure following hemodialysis. It has been hypothesized that these patients are fluid overloaded, ...

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...

Please provide your email address to receive an email when new articles are posted on . Cumulative exposure to increased BP from early adulthood on may influence right ventricular dysfunction in ...

Please provide your email address to receive an email when new articles are posted on . ECGs analyzed by AI identified left ventricular systolic dysfunction in patients who presented to the ED with ...

Through a deep-learning model, researchers have shown that ordinary ECG images can be leveraged to identify patients with an LV ejection fraction below 40%. Their approach also appears able to ...

The drug is now expected to be available in the U.S. in the second half of January 2026. ・The prescribing information for the ...

Cytokinetics has announced that the US Food and Drug Administration (FDA) has approved MYQORZO (aficamten) tablets in 5mg, ...

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...

FDA approved CYTK's Myqorzo for oHCM. It reduces heart's pumping ability, has a warning for heart failure and expected to ...